Katherine M Hannan
4PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.Shunfei Yan, Jiachen Xuan, Natalie Brajanovski
|Jul 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer Progression.Jixuan Gao, MoonSun Jung, Chelsea Mayoh
|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer.Elaine Sanij, Katherine M Hannan, Jiachen Xuan
|Mar 12, 2017
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.Nadine Hein, Donald P Cameron, Katherine M Hannan
Pageof 1
Frequent Collaborators
4 joint publications
Ross D Hannan
3 joint publications
Richard B Pearson
2 joint publications
Karen E Sheppard
2 joint publications
Carleen Cullinane
2 joint publications
Elaine Sanij
2 joint publications
Sarah Ellis
2 joint publications
Keefe T Chan
1 joint publications
Amee J George
1 joint publications
Jian Kang
1 joint publications
Stuart M Pitson
